Would higher doses of methylene blue as well as higher doses of folic acid improve the tolerance of DDDCT and HDDCT by reducing dapsone-induced anemia and its inhibition of the folic acid pathway while further lowering methemoglobin levels, improving tolerability [109,110]? This evidence concerns the gene HBG2 and anemia (phenotype).